Epithalon

✓Key benefits

📈What to expect

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Overview

Epithalon (also spelled Epitalon) is a synthetic version of Epithalamin, a polypeptide naturally produced by the pineal gland. It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, with research spanning over 35 years. The compound's primary claim to significance is its demonstrated ability to activate telomerase - the enzyme responsible for maintaining telomere length. Telomere shortening is one of the hallmarks of cellular aging, and Epithalon remains the only known compound to have shown telomerase activation in human somatic cells in published research.

⚙️How it works

Epithalon activates telomerase, the enzyme that adds protective nucleotide sequences (TTAGGG repeats) to the ends of chromosomes. As cells divide, telomeres naturally shorten - eventually triggering cellular senescence (the cell stops dividing) or apoptosis (programmed cell death). By reactivating telomerase in somatic cells, Epithalon may allow cells to continue dividing beyond the Hayflick limit. Additionally, it has been shown to regulate melatonin production from the pineal gland, normalise circadian rhythms, and modulate the expression of genes involved in antioxidant defence.

⚡Side effects

📅Research history

Vendor ratings are based on community feedback and are not endorsements. Always verify third-party certificates of analysis (CoA) and check current Australian regulations before purchasing.

The telomere connection

Telomeres are protective caps at the ends of chromosomes - often compared to the plastic tips on shoelaces. Each time a cell divides, telomeres shorten slightly. When they become critically short, the cell enters senescence or dies. This process is considered one of the primary drivers of biological aging. Telomerase is the enzyme that can rebuild these protective caps, but it is largely inactive in adult somatic cells (it remains active in stem cells, immune cells, and cancer cells). Epithalon's ability to reactivate telomerase in somatic cells is what makes it unique in the longevity space.

Khavinson's research

The bulk of Epithalon research comes from Professor Vladimir Khavinson's team in St. Petersburg. Their work spans 35+ years and includes both animal and human studies. In animal models, Epithalon extended mean lifespan by 10–25% across multiple species. In a notable human study, elderly patients treated with Epithalamin showed improved immune function, normalised melatonin secretion, and reduced mortality over a 6-year follow-up period compared to controls. Critics note that much of this research is published in Russian-language journals with limited peer review by Western standards.

Reconstitution and protocols

Epithalon typically comes in 10 mg vials. Reconstitute with 2 mL of bacteriostatic water for a concentration of 5 mg/mL. The most common protocol is a 10-day cycle of 5 mg daily (subcutaneous injection), repeated 2–3 times per year. Some protocols use 10 mg daily for 10 days. Unlike many peptides that are used continuously, Epithalon is typically cycled with long breaks between courses.

References

1. [1]Khavinson V, et al. "Peptide epitalon activates chromatin at the old age." Neuroendocrinology Letters, 2003.
2. [2]Khavinson V, et al. "Effect of epithalon on the lifespan increase in Drosophila melanogaster." Mechanisms of Ageing and Development, 2000.
3. [3]Anisimov VN, et al. "Effect of epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice." Biogerontology, 2003.
4. [4]Khavinson V. "Peptides and Ageing." Neuroendocrinology Letters, 2002.

Frequently asked questions

Related peptides